An update on the developments and challenges with the diagnosis and classification of autoimmune optic neuritis
Real-world improvements will depend on standardized diagnostic pathways integrating orbital magnetic resonance imaging (MRI), high-quality antibody assays, OCT, and visual evoked potentials (VEP). Fluid biomarkers such as serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP), together with AI-supported analytics, may refine risk estimates, especially in seronegative cases.
Authors
- Charlotte Bereuter (ORCID: https://orcid.org/0009-0004-7172-8864)
- Jan Schroeter (ORCID: https://orcid.org/0000-0002-9592-9044)
- Frederike Cosima Oertel (ORCID: https://orcid.org/0000-0003-4906-5983)
- Murat Delikaya (ORCID: https://orcid.org/0000-0001-5494-8073)
- Roua Hamdi
Institutions
- Humboldt-Universität zu Berlin (DE)
- Einstein Center Digital Future (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Expert Review of Neurotherapeutics
- Published
- 2026-02-14
- DOI
- https://doi.org/10.1080/14737175.2026.2632795
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00